HSR&D Citation Abstract

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer".

Valle LF, Nickols NG, Yamoah K, Garraway IP, Maxwell KN, Lynch JA. In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer". [Editorial]. The Oncologist. 2023 Nov 2; 28(11):e1129-e1130.

Abstract:

This letter to the editor responds to comments by Sartor et al regarding recent findings on the clinical relevance of CDK12 pathogenic mutations.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.

VA Health Systems Research

HSR&D Citation Abstract

In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer".